These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biased agonism as a mechanism for differential signaling by chemokine receptors. Rajagopal S; Bassoni DL; Campbell JJ; Gerard NP; Gerard C; Wehrman TS J Biol Chem; 2013 Dec; 288(49):35039-48. PubMed ID: 24145037 [TBL] [Abstract][Full Text] [Related]
3. New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model. Kleist AB; Getschman AE; Ziarek JJ; Nevins AM; Gauthier PA; Chevigné A; Szpakowska M; Volkman BF Biochem Pharmacol; 2016 Aug; 114():53-68. PubMed ID: 27106080 [TBL] [Abstract][Full Text] [Related]
4. Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1. Sanchez J; Lane JR; Canals M; Stone MJ Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096719 [TBL] [Abstract][Full Text] [Related]
5. Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10. Lim HD; Lane JR; Canals M; Stone MJ Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921794 [TBL] [Abstract][Full Text] [Related]
6. Endogenous ligand bias by chemokines: implications at the front lines of infection and leukocyte trafficking. Zidar DA Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):120-31. PubMed ID: 21476969 [TBL] [Abstract][Full Text] [Related]
11. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways. Tian Y; New DC; Yung LY; Allen RA; Slocombe PM; Twomey BM; Lee MMK; Wong YH Eur J Immunol; 2004 Mar; 34(3):785-795. PubMed ID: 14991608 [TBL] [Abstract][Full Text] [Related]
12. Allosteric coupling and biased agonism in G protein-coupled receptors. Bock A; Bermudez M FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418 [TBL] [Abstract][Full Text] [Related]
13. The chemokine and chemokine receptor superfamilies and their molecular evolution. Zlotnik A; Yoshie O; Nomiyama H Genome Biol; 2006; 7(12):243. PubMed ID: 17201934 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Regulation of the Chemokine-Receptor Network. Stone MJ; Hayward JA; Huang C; E Huma Z; Sanchez J Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28178200 [TBL] [Abstract][Full Text] [Related]
15. Human Cytomegalovirus US28: a functionally selective chemokine binding receptor. Vomaske J; Nelson JA; Streblow DN Infect Disord Drug Targets; 2009 Nov; 9(5):548-56. PubMed ID: 19594424 [TBL] [Abstract][Full Text] [Related]
16. GPCR systems pharmacology: a different perspective on the development of biased therapeutics. Eiger DS; Pham U; Gardner J; Hicks C; Rajagopal S Am J Physiol Cell Physiol; 2022 May; 322(5):C887-C895. PubMed ID: 35196164 [TBL] [Abstract][Full Text] [Related]
18. Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells. Gouwy M; Struyf S; Leutenez L; Pörtner N; Sozzani S; Van Damme J Immunobiology; 2014 Mar; 219(3):218-29. PubMed ID: 24268109 [TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor. Thompson GL; Lane JR; Coudrat T; Sexton PM; Christopoulos A; Canals M Biochem Pharmacol; 2016 Aug; 113():70-87. PubMed ID: 27286929 [TBL] [Abstract][Full Text] [Related]
20. How can human and simian immunodeficiency viruses utilize chemokine receptors as their coreceptors? Shimizu N; Gojobori T Gene; 2000 Dec; 259(1-2):199-205. PubMed ID: 11163977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]